Rising Replikin Counts in E. Coli in Germany Since 2005 Preceded Current E. Coli Outbreak
Synthetic Replikins Therapeutics for E. Coli Now Available for Testing
LONDON, June 20, 2011 — Scientists Drs. Samuel and Elenore Bogoch of BioRadar UK Ltd. announced that retrospective studies indicate that an increase in Replikin Counts of the EHEC lethal strains of E. Coli preceded the curre…
Flu Natural Remedy: Quercetin Found in Gene-Eden, the Natural Antiviral Supplement
ROCHESTER, N.Y., Nov. 19, 2010 — Recently, researchers discovered that quercetin, a key ingredient in the natural antiviral supplement Gene-Eden, may be beneficial against the flu virus.
The flu virus causes a deadly disease, killing about 40 thousand people annually in the U.S. alone. Worldw…
Boston Biotech Firm Reports First Rise in 76 Years of Replikin Count* of H1N1 Lethality Gene
BOSTON, June 10, 2009 — An analysis of the latest peptide genomic data for the H1N1 influenza virus indicates that the current global outbreak of H1N1 is increasing in its capacity for lethality. The new seq…
BOSTON, April 27, 2009 — Replikins Ltd. published a FluForecast(R) warning in April 7th, 2008, a year before the recent Mexico and California H1N1 cases. The company was able to state the likelihood of H1N1 outbreaks based on its patented Replikin Count(TM) genomics technology, which examines s…
Confirmation of Bogoch Replikins Influenza Patents by Harvard-CDC and Scripps-Crucell Data
BOSTON, March 20, 2009 — Replikins, Ltd. announced today that data recently published from Harvard-CDC and Scripps-Crucell in Nature(1) and Science(2) confirms the 2001 discoveries by Dr. Samuel and Elenore Bogoch of peptides in the hemagglutinin unit of influenza, which they named Replikin…
